# Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

> **NCT07401277** · PHASE1 · RECRUITING · sponsor: **West Virginia University** · enrollment: 32 (estimated)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** 5% 5-fluorouracil (5-FU) powder
- **DRUG:** 5% 5-fluorouracil (5-FU) powder PLUS 15% Aluminum Chloride Hexahydrate (ACH)

## Key facts

- **NCT ID:** NCT07401277
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-06
- **Primary completion:** 2027-07
- **Final completion:** 2027-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07401277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07401277, "Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07401277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*